Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme - Wikidata - awgldk - TriplyDB

Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme

Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme

http://www.wikidata.org/entity/Q24317730

about

A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE).Increased angiotensin II-induced hypertension and inflammatory cytokines in mice lacking angiotensin-converting enzyme N domain activity.Nontraditional roles of angiotensin-converting enzyme.Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease.Roles of Brain Angiotensin II in Cognitive Function and Dementia.Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele.Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide.Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis.Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?Targeting Renin-Angiotensin System Against Alzheimer's Disease.Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.

P2860

8bdedaca083b4cb757beac62031763990cf43511 d3fcdd0daec781f411437c2aba28cb0e888d9d83

P248

Q24306614-3D7A0F4F-6460-4CCB-B39E-F62129DE8CA9 Q26862901-7EDADA8B-AB9E-4A28-A66B-35276C0A094E Q26866225-976F2F43-AA64-4A9B-9812-032DA11E37A5 Q27025597-04660B5A-AA8F-4155-8FFD-F1AE90F19E5B Q30572684-BD362A22-1859-4B14-BCB1-957024DE1006 Q33821846-6A5D9011-04F2-407A-A952-E147F0D9E0FC Q34786191-04A7E3AB-28B2-4373-B7FD-91F308D7B3F5 Q35696855-10181156-BDAC-49DF-87A7-F1BCDAACAC84 Q35836666-B7A2651C-F243-4987-B310-522D8D12BCCE Q36036376-AB9F9363-69AA-4DEF-8931-3AE601E7F3A4 Q36487749-C8111E11-A2E1-4C3D-9C4C-66ACF3D1C971 Q37107046-D3B07133-3B3C-421F-8A05-0B7C8AF3CB75 Q37200279-6AB890DE-79DC-4F86-B2BC-21C99E35E690 Q37415248-DF34DE5B-B776-4E55-A0C9-C3A0D4F530C2 Q37961852-837CC042-1505-4296-8B18-3930E70F7E1E Q38021079-FD4A2014-FD12-4311-A525-8D61731F4BB9 Q39135845-1912C18A-B846-41D7-944D-8175DECAD7E2 Q40032135-39311574-0D2A-4859-87C0-3BC903AE37B8 Q41680485-B099D56C-2F69-4EDA-868B-0931D05487E4 Q44019788-B7320495-2177-4AF4-A6DF-474685D3F60B Q46248584-3FD44176-4B68-431D-A282-371790C96CA9 Q46894741-AF3FF095-8C0E-4A88-8F85-46ABA899172B Q52347539-FF4817E1-794B-46D1-BF5E-48713F5040BF Q55007046-14979CA6-2C15-42B0-92DA-BC28251975D2 Q55346138-242BF599-2E7E-4458-8585-1EC1B54F5F1E

P2860

Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme

http://www.wikidata.org/entity/Q24317730

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@ast

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@en

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@en-gb

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@nl

type

label

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@ast

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@en

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@en-gb

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@nl

prefLabel

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@ast

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@en

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@en-gb

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@nl

P1433

Q24317730-7514466A-6FFC-495B-82CF-A03772BCE98C

P1476

Q24317730-4F6CD41E-42B8-47C0-8346-FB8A8C7747BE

P2093

Q24317730-1FB990FC-6181-4A42-9068-AE2A08332C38

Q24317730-242B7089-09C4-4009-A7D6-C356C44BF65E

Q24317730-375414D3-5AE2-499B-A3B0-80A1665918F7

Q24317730-590B3859-F38C-449D-9B35-1E448DFEFDAF

Q24317730-65BBD74C-8992-4332-8F5F-71BDBB22F7E6

Q24317730-816AC510-8138-424F-821D-E2CD7E632B8C

Q24317730-B479579B-A8E8-442D-9267-497BB43FA8A2

Q24317730-E9451BD8-F234-4A85-96BA-C50EC15DFF00

Q24317730-EE67CF56-0419-4FBD-B6BC-80EEEC8463F8

P2860

Q24317730-095C8B81-4180-4CAB-B540-E3F460C409F2

Q24317730-11AE5AB9-E1B0-4EF6-9512-A2D42B252BCB

Q24317730-17E4FE85-1EC9-49C0-863E-6EBBEBDECA1B

Q24317730-1EDC8958-B46D-4141-ABB2-F4591F10B13C

Q24317730-307E85AC-DBA5-4C64-8379-3BF1DB66ED21

Q24317730-31EC859D-C7EE-48C0-9D46-49B5B928D045

Q24317730-3F98D7F2-781B-433D-B227-E16EF780544C

Q24317730-45F81D45-C405-4E14-9951-FC4571C10AF1

Q24317730-56A3B717-5856-4D65-829E-264AFC4CF903

Q24317730-5AE24E6D-66D6-4FEA-B99D-7AEDA8EBD5C7

P304

Q24317730-3A9EE8E7-A97A-4C0D-BB20-4666439EA88C

P31

Q24317730-5C08ED11-7120-4A1C-B388-4F8B3284E05B

P3181

Q24317730-B6D28323-7552-45E3-812E-112FB633D0AE

P356

Q24317730-06DA05FE-8DC3-4C40-8A07-D49C021E2A0E

P407

Q24317730-B48A36A5-58CF-4A97-9EA1-26927D3088D6

P433

Q24317730-E17D2BBE-D5C0-4669-A83E-EBE06E1B7A83

P478

Q24317730-5FAB2637-4563-4317-A885-22FA14885EFF

P577

Q24317730-8B87342A-5535-4A1E-A6D3-00999C35D49B

P5875

Q24317730-3BE8CAC9-12C7-47DA-8BD4-656CED21908A

P698

Q24317730-81741B94-F114-4BF7-8F69-D01FACCA0E4D

P921

Q24317730-050D5469-7E7A-46AE-8E95-155A61F1392C

Q24317730-A07E9C40-DDE7-4E30-9EA3-22F0404ED43E

Q24317730-D811D8B9-0739-4252-AAC5-9BBD9AFD6FA4

P932

Q24317730-BFB415FC-D373-43C3-8BF3-99550F3D1640

P3181

P356

JBC.M109.011437

P1433

Journal of Biological Chemistry

P1476

Abeta42-to-Abeta40- and angiot ...... angiotensin-converting enzyme

@en

P2093

Atsushi Watanabe

http://www.w3.org/2001/XMLSchema#string

Hiroto Komano

http://www.w3.org/2001/XMLSchema#string

Junjun Liu

http://www.w3.org/2001/XMLSchema#string

Kun Zou

http://www.w3.org/2001/XMLSchema#string

Makoto Michikawa

http://www.w3.org/2001/XMLSchema#string

Ryutaro Oba

http://www.w3.org/2001/XMLSchema#string

Shuyu Liu

http://www.w3.org/2001/XMLSchema#string

Tomoji Maeda

http://www.w3.org/2001/XMLSchema#string

Yoh-ichi Satoh

http://www.w3.org/2001/XMLSchema#string

P2860

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning

The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage.

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.

Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.

P304

31914-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1112903

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M109.011437

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26830814

http://www.w3.org/2001/XMLSchema#string

P698

19773553

http://www.w3.org/2001/XMLSchema#string

P921

Angiotensin I converting enzyme

amyloid-beta metabolic process

P932

2797262

http://www.w3.org/2001/XMLSchema#string